XML 18 R6.htm IDEA: XBRL DOCUMENT v3.20.2
Consolidated Statement of Cash Flows (Statement) - USD ($)
$ in Thousands
3 Months Ended 9 Months Ended 12 Months Ended
Sep. 30, 2020
Sep. 30, 2019
Sep. 30, 2020
Sep. 30, 2019
Dec. 31, 2019
Cash flows from operating activities:          
Net income $ 5,844 $ 20,427 $ 74,589 $ 66,845  
Adjustments to reconcile net income to net cash provided by operating activities:          
Depreciation and amortization     25,836 23,334  
Provision for accounts receivable allowance     (541) 2,109  
Deferred income taxes     7,853 833  
Deferred compensation plan activity     2,487 2,968  
Stock-based compensation expense     23,617 6,046  
Amortization of deferred debt issuance costs     430 415  
Change in fair value of derivative     3,365 159  
Change in fair value of contingent consideration 50   (1,340) 62  
Foreign currency remeasurement (gain) loss     (9,067) 13,956  
Loss from investment accounted for using the equity method, net of tax 581 0 1,447 0  
Changes in assets and liabilities, net of effect from acquisitions:          
Accounts receivable     46,661 40,847  
Prepaid and other assets     8,907 (6,505)  
Accounts payable, accruals and other liabilities     31,486 18,545  
Deferred revenues     (35,134) (39,655)  
Income taxes payable     (4,571) (11,710)  
Net cash provided by operating activities     176,025 118,249  
Cash flows from investing activities:          
Purchases of property and equipment and investment in capitalized software     (12,805) (11,622)  
Capitalization of costs to translate software products into foreign languages     (728) (553)  
Acquisitions, net of cash acquired of $2,064 and $980, respectively     (68,920) (9,662)  
Other investing activities     (6,355) 0  
Net cash used in investing activities     (88,808) (21,837)  
Cash flows from financing activities:          
Proceeds from credit facilities     432,375 136,750  
Payments of credit facilities     (201,125) (147,500)  
Proceeds from term loan     125,000 0  
Payments of debt issuance costs     (432) 0  
Payments of financing leases     (141) 0  
Payments of acquisition debt and other consideration     (2,034) (9,878)  
Payments of dividends     (412,852) (18,830)  
Payments for shares acquired including shares withheld for taxes     (72,476) (18,417)  
Proceeds from Common Stock Purchase Agreement     58,349 4,510  
Net proceeds from exercise of common stock options and restricted stock     3,206 3,039  
Net cash used in financing activities     (70,130) (50,326)  
Effect of exchange rate changes on cash and cash equivalents     (590) (1,272)  
Increase in cash and cash equivalents     16,497 44,814  
Cash and cash equivalents, beginning of year     121,101 81,183 $ 81,183
Cash and cash equivalents, end of period $ 137,598 $ 125,997 137,598 125,997 $ 121,101
Supplemental information:          
Cash paid for income taxes     17,338 24,453  
Income tax refunds     1,630 1,126  
Interest paid     4,658 7,214  
Non-cash contingent acquisition consideration     1,902 50  
Non-cash deferred acquisition consideration     $ (141) $ 0